Director Evans Jae A bought 201 shares of ISABELLA BANK CORP at $49.58; cluster of 6 other insiders buying within 14 days signals coordinated confidence.
Evans Jae A, a director, purchased 201 shares at $49.58 on 2026-01-20, increasing his holdings to 26,953 shares. This transaction is part of a broader cluster pattern: 6 other insiders also bought within the past 14 days at ISABELLA BANK CORP. Cluster buying by multiple insiders is typically noteworthy as it suggests collective assessment of valuation or opportunity. At the same-ticker level, Evans has a mixed track record: his prior buy on 2025-01-24 showed a 90-day return of +0.1%, while an earlier buy on 2024-01-29 returned -14.5% over 90 days—only 1 of 2 prior trades at this ticker was well-timed. The stock is currently trading at $50.70, down 3.1% over the past 30 days but up 41.3% over 90 days. Given the modest share addition (+0.8% of holdings), the P/E of 20.44, and the mixed timing history on prior same-ticker purchases, this filing should be monitored for whether the multi-insider buying pattern translates to sustained stock performance.
Director Evans Jae A bought 387 shares of ISABELLA BANK at $25.80; 5 other insiders bought within 14 days.
Evans Jae A, a director, purchased 387 shares of ISABELLA BANK Corp at $25.80, increasing his holdings by 1.2% to 32,333 shares total. This transaction occurs within a cluster pattern: 5 other insiders also bought within the past 14 days, suggesting coordinated or independently motivated accumulation at this price level. However, this director's cross-ticker track record is concerning—his 1 prior open-market buy showed an average 90-day return of -14.5%, and his same-ticker history at ISBA mirrors this pattern (2024-01-29 buy: 90d return -14.5%). The stock currently trades at $25.79, near its 52-week high of $25.99, with fundamentals showing moderate health (P/E 14.02, annual revenue growth +5.0%). The insider's historical timing accuracy on buys is 0.00%, indicating his prior purchases have not been followed by near-term gains.
